CRESCENT2: Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)

Sponsor
Erasmus Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02291484
Collaborator
(none)
250
4
2
33
62.5
1.9

Study Details

Study Description

Brief Summary

Multi-center, randomized-controlled trial comparing a comprehensive cardiac CT protocol with standard stress testing in patients with stable chest pain complaints.

Condition or Disease Intervention/Treatment Phase
  • Device: Cardiac CT scan
Phase 3

Detailed Description

Rationale: CT calcium and coronary lumen imaging allow efficient exclusion of coronary artery disease (CAD), but cannot assess the hemodynamic significance of obstructive findings. Addition of stress myocardial perfusion imaging, which assesses the functional relevance of coronary narrowing, completes the non-invasive cardiac evaluation.

Hypothesis: A comprehensive cardiac CT examination will allow fast, accurate and complete evaluation of suspected CAD.

Objective: evaluate the effectiveness and efficiency of comprehensive cardiac CT workup of suspected CAD.

Study design: Open-labelled, randomized-controlled, clinical efficiency trial, with an intention-to-diagnose approach, between CT-guided management and the current standard of care (based on functional testing of provocable myocardial ischemia) in patients with suspected CAD.

Study population: 250 patients (>18 yrs) with stable chest complaints, a >10% pre-test probability of CAD, and referred for evaluation of possible CAD.

Intervention: Instead of the usual diagnostic approach, patients in the intervention group will undergo in sequence the following CT examinations: coronary calcium scan, coronary CT angiography and CT myocardial perfusion imaging, with completion dependent on results. Findings on CT will direct further management.

Main study parameters/endpoints:
Primary: Rate of negative invasive angiograms (as percentage of total population) Secondary:

Diagnostic yield, chest complaints, quality of life, diagnostic and therapeutic procedures, overall costs and adverse events at 6 months.

Study Design

Study Type:
Interventional
Actual Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comprehensive Cardiac CT Versus Exercise Testing in Suspected Coronary Artery Disease (2)
Study Start Date :
Aug 1, 2013
Actual Primary Completion Date :
May 1, 2016
Actual Study Completion Date :
May 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Comprehensive cardiac CT

Tiered cardiac CT protocol: CT calcium scan CT angiography (if calcium scan positive or high pre-test probability) CT perfusion (if >50% stenosis on CTA, or cannot be ruled out)

Device: Cardiac CT scan
CT-guided management

No Intervention: Standard care

Standard diagnostic management of suspected CAD, using stress testing

Outcome Measures

Primary Outcome Measures

  1. Rate of negative invasive angiograms (as percentage of total population) [6 months]

    Number of performed invasive angiograms with no CAD requiring intervention

Secondary Outcome Measures

  1. Chest pain complaints [6 months]

    Proportion of patients experiencing symptoms of chest pain

  2. Quality of life [6 months]

    Questionnaire based quality of life score

  3. Major adverse event rate [6 months]

    Death, myocardial infarction, unstable angina, urgent revascularizations, CVA

  4. Radiation exposure [6 months]

    Cumulative radiation dose from diagnostic and therapeutic interventions

  5. Number of diagnostic and therapeutic procedures [6 months]

    Number of diagnostic and therapeutic procedures

  6. Medical expenses [6 months]

    All medical expenses related to the diagnosis and treatment of suspected CAD

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Men and women aged >18 years.

  • Chest pain symptoms suspicious of coronary heart disease.

  • Pre-test probability of coronary artery disease >10%

Exclusion Criteria:
  • History of CAD: prior myocardial infarction or revascularization procedure

  • Contra-indication to radiation exposure (CT/SPECT): pregnancy

  • Contra-indication to iodine contrast media: renal failure, iodine allergy

  • Contra-indications to adenosine

  • Inability or unwillingness to provide informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Albert Schweizerzieknhuis Dordrecht Netherlands 3318 AT
2 Maastricht University Medical Center Maastricht Netherlands 6229 HX
3 Erasmus MC Rotterdam Netherlands 3015CE
4 Maasstadziekenhuis Rotterdam Netherlands

Sponsors and Collaborators

  • Erasmus Medical Center

Investigators

  • Principal Investigator: Koen Nieman, MD, PhD, Erasmus MC

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Koen Nieman, Dr K Nieman, Erasmus Medical Center
ClinicalTrials.gov Identifier:
NCT02291484
Other Study ID Numbers:
  • MEC2013022
First Posted:
Nov 14, 2014
Last Update Posted:
Aug 4, 2016
Last Verified:
Aug 1, 2016
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Koen Nieman, Dr K Nieman, Erasmus Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2016